These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 25758277)
1. Retroperitoneal fibrosis: a retrospective clinical data analysis of 30 patients in a 10-year period. Zhou HJ; Yan Y; Zhou B; Lan TF; Wang XY; Li CS Chin Med J (Engl); 2015 Mar; 128(6):804-10. PubMed ID: 25758277 [TBL] [Abstract][Full Text] [Related]
2. Retroperitoneal fibrosis in 27 Korean patients: single center experience. Ha YJ; Jung SJ; Lee KH; Lee SW; Lee SK; Park YB J Korean Med Sci; 2011 Aug; 26(8):985-90. PubMed ID: 21860546 [TBL] [Abstract][Full Text] [Related]
3. Multi-institutional survey of laparoscopic ureterolysis for retroperitoneal fibrosis. Duchene DA; Winfield HN; Cadeddu JA; Clayman RV; Gomella LG; Kavoussi LR; Mikhail AA; Park S; Permpongkosol S; Shalhav AL Urology; 2007 Jun; 69(6):1017-21. PubMed ID: 17572177 [TBL] [Abstract][Full Text] [Related]
4. [Clinical characteristics of IgG4 related retroperitoneal fibrosis: a report of 5 cases and literature review]. Dun YJ; Yu LP; Du YQ; Sheng ZZ; Wang GW; Li X; Yang B; Xu T; Huang XB; Wang XF Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Aug; 47(4):622-7. PubMed ID: 26284398 [TBL] [Abstract][Full Text] [Related]
5. [Diagnosis and treatment of retroperitoneal fibrosis: report of 26 cases]. Cai L; Zhou LQ; He ZS; Li NC; Pan BN Zhonghua Wai Ke Za Zhi; 2008 May; 46(10):749-51. PubMed ID: 18953929 [TBL] [Abstract][Full Text] [Related]
6. IgG4-related retroperitoneal fibrosis: a newly characterized disease. Lian L; Wang C; Tian JL Int J Rheum Dis; 2016 Nov; 19(11):1049-1055. PubMed ID: 27125330 [TBL] [Abstract][Full Text] [Related]
7. [Treatment outcomes in primary and secondary retroperitoneal fibrosis]. Heidenreich A; Derakhshani P; Neubauer S; Krug B Urologe A; 2000 Mar; 39(2):141-8. PubMed ID: 10768224 [TBL] [Abstract][Full Text] [Related]
8. Contemporary role of ureterolysis in retroperitoneal fibrosis: treatment of last resort or first intent? An analysis of 50 cases. O'Brien T; Fernando A BJU Int; 2017 Oct; 120(4):556-561. PubMed ID: 28502080 [TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic characteristics of IgG4-related retroperitoneal fibrosis among patients initially diagnosed as having idiopathic retroperitoneal fibrosis. Koo BS; Koh YW; Hong S; Kim YJ; Kim YG; Lee CK; Yoo B Mod Rheumatol; 2015 Mar; 25(2):194-8. PubMed ID: 25036229 [TBL] [Abstract][Full Text] [Related]
10. Rituximab for idiopathic and IgG4-related retroperitoneal fibrosis. Wallwork R; Wallace Z; Perugino C; Sharma A; Stone JH Medicine (Baltimore); 2018 Oct; 97(42):e12631. PubMed ID: 30334947 [TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics of IgG4-related retroperitoneal fibrosis versus idiopathic retroperitoneal fibrosis. Wang K; Wang Z; Zeng Q; Zhu L; Gao J; Wang Z; Zhang S; Yang F; Shen D; Wang Y; Liu Y PLoS One; 2021; 16(2):e0245601. PubMed ID: 33600452 [TBL] [Abstract][Full Text] [Related]
12. [Clinical features and prognostic analysis of retroperitoneal fibrosis in 32 patients]. An LM; Xu YF; Zhang ZL Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Apr; 44(2):265-9. PubMed ID: 22517001 [TBL] [Abstract][Full Text] [Related]
13. Long-term outcome of idiopathic retroperitoneal fibrosis treated with surgical and/or medical approaches. Moroni G; Gallelli B; Banfi G; Sandri S; Messa P; Ponticelli C Nephrol Dial Transplant; 2006 Sep; 21(9):2485-90. PubMed ID: 16702201 [TBL] [Abstract][Full Text] [Related]
14. Primary and postoperative retroperitoneal fibrosis-experience with 18 cases. Katz R; Golijanin D; Pode D; Shapiro A Urology; 2002 Nov; 60(5):780-3. PubMed ID: 12429295 [TBL] [Abstract][Full Text] [Related]
15. Tamoxifen monotherapy in the treatment of retroperitoneal fibrosis. Brandt AS; Kamper L; Kukuk S; Haage P; Roth S Urol Int; 2014; 93(3):320-5. PubMed ID: 25073896 [TBL] [Abstract][Full Text] [Related]